Galenica S.A

About Galenica S.A

Galenica is one of the largest Greek pharmaceutical companies which promotes research and serves health with consistency and scientific responsibility, by developing high-quality and innovative pharmaceutical products. Founded in 1974 by the pharmacists Denis Varelas and Basile Tamvacas, it became very soon one of the most dynamic companies in the sector with impressive rates of growth and development. It is the first Greek company that focused on the acquisition of know how and marketing of ethical products, through the cooperation with well established foreign research based pharmaceutical companies. Galenica has  a strong in-licensed product portfolio sold mainly in Greece,  Cyprus, Romania, Bulgaria and is focusing in development of new dosage forms of known compounds  and products of natural origin for out –licensing. With a dedicated and experienced exports department in constant search of new markets and successful international partnerships we continue to expand our global activities. One of the primary success factors of Galenica lies with its distinguished business partners all over the world. The history of many and successful partnerships gives the company the strategic advantage to select with very strict criteria the pharmaceutical products that it develops into therapeutic and business values.

  • GR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Licensee
Manufacturer/Innovator
Other
Pharmaceutical company
Primary activities
Contract Manufacturer
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

CPHI Barcelona 2023

Fira Barcelona, Spain
24-26 October 2023

Products from Galenica S.A (6)

  • CRETAN IAMA

    Product CRETAN IAMA

    CRETAN IAMA is a unique Greek natural product which has been developed after many years of research by distinguished researchers at the University of Crete who achieved to evolve the traditional practice into substantial knowledge. The long term scientific research has highlighted a combination of essentia...
  • DIMENHYDRINATE SUBLINGUAL

    Product DIMENHYDRINATE SUBLINGUAL

    Active ingredient: Dimenhydrinate Strength: 50mg/tab
    Pharmaceutical form: sublingual tablets, BTX4, BTX10, BTX20
    Therapeutic target: Antinausea - motion sickness. 
    Contact us for more information.
  • DEXARIS

    Product DEXARIS

    Active ingredients:   Dexamethasone isonicotinate/ Oxymetazoline hydrochlorideStrength: 0,2028 mg+0,5 mg / ml
    Pharmaceutical form: Nasal spray 15 ml
    Therapeutic indications:
    Allergic rhinitis (hay fever, vasomotor rhinitis), acute rhinitis and rhinopharyngitis, sinusitis and nas...
  • DERMISET

    Product DERMISET

    Indications: 
    Eczema and corticosteroid-responsive skin diseases characterized by hyperkeratoses and/or squamous cell formation.
    Psoriasis, excluding large psoriasis plaques
    Lichenification of the skin.
    Neurodermatitis
    Lichen planus
    Keratoderma palmoplantaris(palmoplantar hyperkera...
  • NAPHAZOLINE NASAL SPRAY GALENICA

    Product NAPHAZOLINE NASAL SPRAY GALENICA

    Active ingredient: Naphazoline NitrateStrength: 1mg/ml
    Pharmaceutical form: Nasal spray in 10 ml bottle
    Category: Nasal decongestant
    Under registration
  • CAL-D-VIT

    Product CAL-D-VIT

    Active ingredients: Calcium carbonate / Cholecalciferol (vit D3)
    Pharmaceutical form: Chewable tablets
    Strength: 600 mg + 1000 IU/chew.tab
    Packaging: BTX28, 30, 56, 60